Skip to content
MedsAcross

Brand family

Fycompa

Perampanel · Catalyst Pharmaceuticals
United States
Presentations
7
Markets
1

Fycompa is a brand of Perampanel marketed by Catalyst Pharmaceuticals, with 7 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Perampanel
Brand owner
Catalyst Pharmaceuticals
Registered in
United States
Strengths and forms
0.5 mg/mL oral suspension, 10 mg tablet, 12 mg tablet, 2 mg tablet, 4 mg tablet, 6 mg tablet, 8 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Fycompa 0.5 mg/mL oral suspensionOralCatalyst PharmaceuticalsUS FDAAvailable on request
Fycompa 10 mg tabletOralCatalyst PharmaceuticalsUS FDAAvailable on request
Fycompa 12 mg tabletOralCatalyst PharmaceuticalsUS FDAAvailable on request
Fycompa 2 mg tabletOralCatalyst PharmaceuticalsUS FDAAvailable on request
Fycompa 4 mg tabletOralCatalyst PharmaceuticalsUS FDAAvailable on request
Fycompa 6 mg tabletOralCatalyst PharmaceuticalsUS FDAAvailable on request
Fycompa 8 mg tabletOralCatalyst PharmaceuticalsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Fycompa

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.